Recruitment of Podoplanin Positive Cancer-Associated Fibroblasts in Metastatic Lymph Nodes Predicts Poor Prognosis in Pathological N2 Stage III Lung Adenocarcinoma

被引:0
|
作者
Shinya Neri
Genichiro Ishii
Tetsuhiko Taira
Tomoyuki Hishida
Junji Yoshida
Mitsuyo Nishimura
Kanji Nagai
Atsushi Ochiai
机构
[1] National Cancer Center Hospital East,Pathology Division, Research Center for Innovative Oncology
[2] National Cancer Center Hospital East,Division of Thoracic Oncology
来源
关键词
Lung Adenocarcinoma; Metastatic Lesion; Metastatic Lymph Node; Metastatic Site; Lymphatic Endothelial Cell;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3953 / 3962
页数:9
相关论文
共 50 条
  • [21] Podoplanin-positive Cancer-associated Stromal Fibroblasts in Primary Tumor and Synchronous Lymph Node Metastases of HER2-overexpressing Breast Carcinomas
    Niemiec, Joanna
    Adamczyk, Agnieszka
    Harazin-Lechowska, Agnieszka
    Ambicka, Aleksandra
    Grela-Wojewoda, Aleksandra
    Majchrzyk, Kaja
    Kruczak, Anna
    Sas-Korczynska, Beata
    Rys, Janusz
    ANTICANCER RESEARCH, 2018, 38 (04) : 1957 - 1965
  • [22] Pathological complete response to neoadjuvant chemoimmunotherapy correlates with peripheral blood immune cell subsets and metastatic status of mediastinal lymph nodes (N2 lymph nodes) in non-small cell lung cancer
    Ma, Tianyu
    Wen, Tao
    Cheng, Xu
    Wang, Yuxuan
    Wei, Panjian
    Yang, Bing
    Yi, Ling
    Wang, Xiaojue
    Yan, Zhuohong
    Wang, Jinghui
    Liu, Zhidong
    LUNG CANCER, 2022, 172 : 43 - 52
  • [23] Survival Impact of Stations of Pathological Lymph Nodes in N2 Non-small Cell Lung Cancer in a French Hospital
    Clement-Duchene, Christelle
    Luc, Amandine
    Casse, Jean-Matthieu
    Vignaud, Jean-Michel
    Lacomme, Stephanie
    Anne, Valentine
    Siat, Joelle
    Menard, Olivier
    Martinet, Yves
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (05) : 1262 - 1268
  • [24] Survival Impact of Stations of Pathological Lymph Nodes in N2 Non-small Cell Lung Cancer in a French Hospital
    Christelle Clément-Duchêne
    Amandine Luc
    Jean-Matthieu Casse
    Jean-Michel Vignaud
    Stéphanie Lacomme
    Valentine Anne
    Joëlle Siat
    Olivier Ménard
    Yves Martinet
    Annals of Surgical Oncology, 2018, 25 : 1262 - 1268
  • [25] Impact of the number of metastatic lymph nodes on survival in pathological stage II-N1 non-small cell lung cancer
    de Ruiter, J.
    de Langen, A.
    Monkhorst, K.
    Veenhof, A.
    Klomp, H.
    Damhuis, R.
    Hartemink, K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S703 - S703
  • [26] Role of skip N2 lymph node metastasis for patients with the stage III-N2 lung adenocarcinoma: a propensity score matching analysis
    Shize Wang
    Shaonan Xie
    Yaqing Han
    Maogang Gao
    Xin Su
    Qingyi Liu
    BMC Pulmonary Medicine, 23
  • [27] Classifications of N2 None-Small-Cell Lung Cancer Based on the Number and Rate of Metastatic Mediastinal Lymph Nodes
    Ito, Masaoki
    Yamashita, Yoshinori
    Tsutani, Yasuhiro
    Misumi, Keizo
    Harada, Hiroaki
    Miyata, Yoshihiro
    Okada, Morihito
    CLINICAL LUNG CANCER, 2013, 14 (06) : 651 - 657
  • [28] Role of skip N2 lymph node metastasis for patients with the stage III-N2 lung adenocarcinoma: a propensity score matching analysis
    Wang, Shize
    Xie, Shaonan
    Han, Yaqing
    Gao, Maogang
    Su, Xin
    Liu, Qingyi
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [29] Suggestions on "Pathological complete response to neoadjuvant chemoimmunotherapy correlates with peripheral blood immune cell subsets and metastatic status of mediastinal lymph nodes (N2 lymph nodes) in non-small cell lung cancer"
    Yu, Yixuan
    Zheng, Jiabin
    Han, Zelu
    Cui, Huijuan
    LUNG CANCER, 2023, 175 : 152 - 153
  • [30] Presence of podoplanin-positive cancer-associated fibroblasts in surgically resected primary lung adenocarcinoma predicts a shorter progression-free survival period in patients with recurrences who received platinum-based chemotherapy
    Haruki Koriyama
    Genichiro Ishii
    Kiyotaka Yoh
    Shinya Neri
    Masahiro Morise
    Shigeki Umemura
    Shingo Matsumoto
    Seiji Niho
    Hironobu Ohmatsu
    Masahiro Tsuboi
    Koichi Goto
    Atsushi Ochiai
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 1163 - 1170